Monthly ReportJan 1–31, 2025
Anesthesiology, January 2025 edition
We read 102 papers and selected 5.
Summary
January 2025 anesthesiology research moved toward precision, physiology-guided care, with major advances in anesthetic mechanisms, individualized hemodynamic management, and perioperative safety. Translational studies identified actionable molecular and immune targets, including anti-rocuronium IgE epitopes, cortical circuits underlying burst suppression, and orexin-2 signaling for opioid-induced respiratory depression. Large randomized and evidence-synthesis studies refined clinical policies, supporting early ward-based NIV, exercise- and nutrition-centered prehabilitation, and broad prophylactic tranexamic acid use while tempering expectations for benzodiazepine restriction or TIVA as universal delirium or cancer-recurrence interventions. Digital decision support, machine-learning endotyping, and multimodal monitoring emerged as sustained directions for reducing low-value care and enabling mechanism-based treatment.
Selected Articles
1. TAK-925 (Danavorexton), an Orexin Receptor 2 Agonist, Reduces Opioid-induced Respiratory Depression and Sedation without Affecting Analgesia in Healthy Men.
In a double-blind, placebo-controlled crossover phase 1 trial involving 13 healthy men, danavorexton dose-dependently increased minute ventilation, tidal volume, and respiratory rate during remifentanil-induced respiratory depression. It reduced sedation without reducing experimentally measured pain tolerance, and respiratory benefits persisted after infusion.
Impact: It is the first randomized human evidence for an orexin-2 agonist that may reverse opioid-related respiratory depression while preserving analgesia, offering a potential alternative to naloxone-centered rescue.
Clinical Implications: If replicated in patients with perioperative respiratory depression, opioid tolerance, or overdose, orexin-2 agonists could provide targeted respiratory stimulation without precipitating analgesia loss or withdrawal. Safety and efficacy in clinical populations remain unestablished.
Key Findings
- Danavorexton increased minute ventilation by approximately 8.2 and 13.0 L/min at low and high doses versus placebo.
- The high dose reduced sedation scores without changing experimentally measured pain tolerance.
- Respiratory improvements persisted after infusion, and adverse events were generally mild.
2. Antibody-secreting cell repertoires hold high-affinity anti-rocuronium specificities that can induce anaphylaxis in vivo.
This translational study used single-cell VH/VL sequencing, structural crystallography, and FcεRI-humanized mice to identify high-affinity human-format anti-rocuronium antibodies. The antibodies activated human effector cells and caused severe anaphylaxis in vivo, while structural analyses mapped distinct epitopes involving the ammonium moiety.
Impact: It provides direct mechanistic evidence that defined anti-rocuronium IgE specificities can cause perioperative anaphylaxis and establishes a foundation for epitope-resolved allergy diagnostics.
Clinical Implications: The findings may enable improved preoperative risk stratification, informed selection or avoidance of neuromuscular blockers, and future development of desensitization or alternative-agent strategies. Clinical testing remains necessary before routine use.
Key Findings
- More than 500 VH-VL pairs included antibody families with subnanomolar affinity for rocuronium.
- Human IgE versions activated mast cells and basophils and caused severe passive systemic anaphylaxis in humanized mice.
- Cocrystal structures identified distinct rocuronium-binding modes involving the ammonium group.
3. Synchronicity of pyramidal neurones in the neocortex dominates isoflurane-induced burst suppression in mice.
Using EEG, micro-endoscopic calcium imaging, and chemogenetic manipulation, this mouse study showed that isoflurane-induced burst suppression is driven primarily by synchronized cortical pyramidal-neuron activity. Bidirectional manipulation of parvalbumin interneurons altered cortical synchrony and burst suppression, implicating inhibitory microcircuits in anesthetic-state control.
Impact: The study provides causal circuit-level evidence for a clinically familiar EEG pattern and may improve interpretation of deep-anesthesia monitoring.
Clinical Implications: The findings may guide development of EEG biomarkers that better reflect cortical inhibitory tone and help identify patients vulnerable to excessive anesthetic depth, although translation from mice to humans is required.
Key Findings
- Burst suppression was strongly correlated with synchronous cortical pyramidal-neuron activity.
- Chemogenetic activation or inhibition of parvalbumin interneurons bidirectionally changed cortical synchrony and burst suppression.
- SST and VIP interneurons and subcortical structures showed limited correlation with the burst-suppression pattern in this model.
4. Relative efficacy of prehabilitation interventions and their components: systematic review with network and component network meta-analyses of randomised controlled trials.
This network and component network meta-analysis of 186 randomized trials involving 15,684 participants found that exercise and nutritional prehabilitation, alone or combined, reduced postoperative complications and hospital stay. Exercise and nutrition were identified as the dominant components, while adding psychosocial interventions improved health-related quality of life and functional recovery.
Impact: It provides decision-grade comparative evidence on which prehabilitation components are most effective, directly supporting pathway design and resource allocation.
Clinical Implications: Perioperative programs should prioritize exercise and nutritional optimization, with psychosocial support added when functional recovery and quality of life are key objectives. Program intensity and patient selection should be individualized.
Key Findings
- Exercise prehabilitation reduced postoperative complications compared with usual care, with an odds ratio of approximately 0.50.
- Nutritional prehabilitation reduced complications, with an odds ratio of approximately 0.62.
- Component analysis identified exercise and nutrition as the dominant contributors to improved complications, length of stay, quality of life, and function.
5. Benzodiazepine-Free Cardiac Anesthesia for Reduction of Postoperative Delirium: A Cluster Randomized Crossover Trial.
This pragmatic cluster randomized crossover trial across 20 cardiac centers compared restrictive and liberal institutional intraoperative benzodiazepine policies in approximately 19,768 patients. Restriction did not significantly reduce delirium within 72 hours, but adherence was high and there was no increase in reported intraoperative awareness.
Impact: As the largest randomized policy evaluation of benzodiazepine restriction in cardiac anesthesia, it provides robust evidence against assuming that an institutional restriction alone will substantially reduce delirium.
Clinical Implications: Hospitals should avoid expecting large delirium reductions from blanket benzodiazepine bans alone. Patient-level risk factors, alternative anesthetic strategies, and multimodal delirium prevention should be considered.
Key Findings
- Delirium within 72 hours occurred in 14.0% of the restrictive-policy group and 14.9% of the liberal-policy group.
- The adjusted odds ratio was 0.92 with a P value of 0.07, indicating no statistically significant reduction.
- Policy adherence was high and there was no increase in patient-reported intraoperative awareness.